Oslo - Delayed Quote NOK

Oncoinvent ASA (ONCIN.OL)

1.6060
+0.0160
+(1.01%)
At close: May 16 at 4:16:32 PM GMT+2
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,729
2,729
63
67
Cost of Revenue
12,033
12,033
19,688
10,233
Gross Profit
-9,304
-9,304
-19,625
-10,166
Operating Expense
131,714
131,714
127,800
100,446
Operating Income
-141,018
-141,018
-147,425
-110,612
Net Non Operating Interest Income Expense
816
816
3,804
4,438
Pretax Income
-140,202
-140,202
-143,621
-106,281
Net Income Common Stockholders
-140,201
-140,201
-143,621
-106,280
Diluted NI Available to Com Stockholders
-140,201
-140,201
-143,621
-106,280
Basic EPS
-1.52
--
-5.41
-4.00
Diluted EPS
-1.52
--
-5.41
-4.00
Basic Average Shares
92,243.3430
--
26,548.6740
26,548.6740
Diluted Average Shares
92,243.3430
--
26,548.6740
26,548.6740
Total Operating Income as Reported
--
--
-147,425
-110,611
Total Expenses
143,747
143,747
147,488
110,679
Net Income from Continuing & Discontinued Operation
-140,201
-140,201
-143,621
-106,280
Normalized Income
-140,201
-140,201
-143,621
-106,280
Interest Income
--
--
4,408
4,444
Interest Expense
--
--
9
6
Net Interest Income
816
816
3,804
4,438
EBIT
-141,018
-141,018
-147,425
-106,275
EBITDA
-126,463
-126,463
-136,168
-98,288
Reconciled Cost of Revenue
12,033
12,033
19,688
10,233
Reconciled Depreciation
14,555
14,555
11,257
7,987
Net Income from Continuing Operation Net Minority Interest
-140,201
-140,201
-143,621
-106,280
Normalized EBITDA
-126,463
-126,463
-136,168
-98,288
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 12/13/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZLNA.OL Zelluna ASA
13.75
-1.06%
 
ABS.OL Arctic Bioscience AS
3.8500
+4.05%
 
CRNA.OL Circio Holding ASA
0.6270
-4.27%
 
PCIB.OL PCI Biotech Holding ASA
1.7600
-5.38%
 
LYTIX.OL Lytix Biopharma AS
7.60
-1.30%
 
BGBIO.OL BerGenBio ASA
1.7500
+2.58%
 
HURA TuHURA Biosciences, Inc.
3.9200
+2.08%
 
VRCA Verrica Pharmaceuticals Inc.
0.6623
+3.19%
 
VSTM Verastem, Inc.
7.59
-4.29%